5E Advanced Materials, Inc. (ASX: $5EA) has extended its Standstill Agreement with BEP Special Situations IV LLC, Alter Domus (US) LLC, Ascend Global Investment Fund SPC, and Mayfair Ventures Pte Ltd. The company has entered into a Restructuring Support Agreement with Bluescape, Collateral Agent, and Ascend for certain restructuring and recapitalization transactions. The Transaction includes a potential $35 million placement of the company's common stock, an amendment to the conversion price of Convertible Notes, and an increase in paid-in-kind interest. The company also announced the appointment of Stefan Selig as a director of the Board. Additionally, the company has entered into retention agreements for its Chief Executive Officer and Chief Financial Officer in connection with the anticipated restructuring.
The company is pleased to announce the extension of the Standstill Agreement and the entry into the Restructuring Support Agreement, which are significant steps in our efforts to restructure and recapitalize the company. The potential $35 million placement of common stock and the amendment to the conversion price of Convertible Notes demonstrate the commitment of our strategic investors to support our future growth and operations. The appointment of Stefan Selig to the Board brings valuable expertise and leadership to our team. We believe that these agreements and appointments will position us for a stronger financial foundation and operational growth.
5E Advanced Materials, Inc. (5EA) has extended its Standstill Agreement and entered into a Restructuring Support Agreement, securing potential new equity capital of up to $35 million. The Transaction includes a placement of the company's common stock, an amendment to the conversion price of Convertible Notes, and an increase in paid-in-kind interest. The company also appointed Stefan Selig as a director of the Board. The proposed restructuring aims to strengthen the company's balance sheet, fund its next phase of growth, and commence operations. The company expects to file a proxy statement with the SEC in connection with the Transaction and certain stockholder approvals required thereby.